nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alternative business models for drug discovery
|
Bunin, Barry A. |
|
2011 |
16 |
15-16 |
p. 643-645 3 p. |
artikel |
2 |
Animal models of asthma: value, limitations and opportunities for alternative approaches
|
Holmes, Anthony M. |
|
2011 |
16 |
15-16 |
p. 659-670 12 p. |
artikel |
3 |
A procedural framework for good imaging practice in pharmacological fMRI studies applied to drug development #2: protocol optimization and best practices
|
Schwarz, Adam J. |
|
2011 |
16 |
15-16 |
p. 671-682 12 p. |
artikel |
4 |
Biopharma business models in Canada
|
March-Chordà, I. |
|
2011 |
16 |
15-16 |
p. 654-658 5 p. |
artikel |
5 |
Contents page 2
|
|
|
2011 |
16 |
15-16 |
p. iii- 1 p. |
artikel |
6 |
Contents page 1
|
|
|
2011 |
16 |
15-16 |
p. i- 1 p. |
artikel |
7 |
DNA demethylases: a new epigenetic frontier in drug discovery
|
Carey, Nessa |
|
2011 |
16 |
15-16 |
p. 683-690 8 p. |
artikel |
8 |
Erratum to: Heparin/heparan sulphate-based drugs
|
Gandhi, Neha S. |
|
2011 |
16 |
15-16 |
p. 741- 1 p. |
artikel |
9 |
FDA-approved drug labeling for the study of drug-induced liver injury
|
Chen, Minjun |
|
2011 |
16 |
15-16 |
p. 697-703 7 p. |
artikel |
10 |
Follow-on drugs: How far should chemists look?
|
Giordanetto, Fabrizio |
|
2011 |
16 |
15-16 |
p. 722-732 11 p. |
artikel |
11 |
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery – the GSK experience
|
Vanderwall, Dana E. |
|
2011 |
16 |
15-16 |
p. 646-653 8 p. |
artikel |
12 |
mTOR as a multifunctional therapeutic target in HIV infection
|
Nicoletti, Ferdinando |
|
2011 |
16 |
15-16 |
p. 715-721 7 p. |
artikel |
13 |
Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
|
Kell, Douglas B. |
|
2011 |
16 |
15-16 |
p. 704-714 11 p. |
artikel |
14 |
Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat
|
Torabi-Rahvar, Monireh |
|
2011 |
16 |
15-16 |
p. 733-740 8 p. |
artikel |
15 |
ROCK: the Roche medicinal chemistry knowledge application – design, use and impact
|
Mayweg, Alexander |
|
2011 |
16 |
15-16 |
p. 691-696 6 p. |
artikel |
16 |
The solution-phase design and synthesis of libraries for the discovery of CNS active substances
|
Edwards, Paul John |
|
2011 |
16 |
15-16 |
p. 742-744 3 p. |
artikel |